• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球海绵体肌面积作为性腺功能减退的一种新型标志物。

Bulbocavernosus muscle area as a novel marker for hypogonadism.

作者信息

Gupta Nikhil, Carvajal Maria, Jurewicz Michael, Gilbert Bruce R

机构信息

Hofstra-Northwell School of Medicine, Smith Institute for Urology, New Hyde Park, NY, USA.

出版信息

Asian J Urol. 2017 Jan;4(1):3-9. doi: 10.1016/j.ajur.2016.11.002. Epub 2016 Nov 28.

DOI:10.1016/j.ajur.2016.11.002
PMID:29264199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5730903/
Abstract

OBJECTIVE

Late-onset hypogonadism, or androgen deficiency in the aging male, is a significant cause of morbidity in older men. Many men in the low normal or equivocal range for low testosterone level exhibit signs and symptoms of hypogonadism. Serum testosterone is an imperfect maker for hypogonadism as symptoms vary greatly within the low to low normal range in addition to variations among testosterone assays. Perineal ultrasound can be effectively used to examine the bulbocavernosus muscle (BCM), an androgenized tissue that may be impacted by androgen receptor activity.

METHODS

This study was a retrospective analysis of men who underwent perineal ultrasound for hypogonadism. The ultrasound data were used to calculate the area of the BCM and correlate it with indices of hypogonadismin symptomatic men including free and total testosterone and dual-energy X-ray absorptiometry (DEXA).

RESULTS

The results demonstrate that there is a significant correlation between total and free testosterone and BCM area in hypogonadal patients. Comparison between BCM area and total testosterone showed  = 0.061 and  = 0.0187 and comparison between BCM area and free testosterone showed  = 0.0957 and  = 0.0034. In addition, low BCM was also correlated with DEXA results showing osteoporosis and osteopenia (  = 0.2239,  = 0.0027).

CONCLUSION

There has been recent controversy over the safety of testosterone replacement therapy. This might be particularly important in men with hypogonadal symptoms but a low normal testosterone level. Our study investigated the use of perineal ultrasound to measure BCM as a surrogate marker for poor androgenized men presenting with hypogonadism.

摘要

目的

迟发性性腺功能减退,即老年男性雄激素缺乏,是老年男性发病的重要原因。许多睾酮水平处于低正常范围或临界范围的男性表现出性腺功能减退的体征和症状。血清睾酮作为性腺功能减退的指标并不理想,因为在低至低正常范围内症状差异很大,而且不同的睾酮检测方法之间也存在差异。会阴超声可有效用于检查球海绵体肌(BCM),这是一种可能受雄激素受体活性影响的雄激素化组织。

方法

本研究是对因性腺功能减退接受会阴超声检查的男性进行的回顾性分析。超声数据用于计算BCM的面积,并将其与有症状男性的性腺功能减退指标相关联,这些指标包括游离睾酮、总睾酮和双能X线吸收法(DEXA)。

结果

结果表明,性腺功能减退患者的总睾酮、游离睾酮与BCM面积之间存在显著相关性。BCM面积与总睾酮的比较显示r = 0.061,P = 0.0187;BCM面积与游离睾酮的比较显示r = 0.0957,P = 0.0034。此外,低BCM也与显示骨质疏松和骨质减少的DEXA结果相关(r = 0.2239,P = 0.0027)。

结论

最近关于睾酮替代疗法的安全性存在争议。这对有性腺功能减退症状但睾酮水平处于低正常范围的男性可能尤为重要。我们的研究调查了使用会阴超声测量BCM作为性腺功能减退的雄激素化不良男性的替代标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/1a27cea97b48/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/c7a928fb1acc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/2c36589e8450/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/ab464fe2c69e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/1a27cea97b48/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/c7a928fb1acc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/2c36589e8450/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/ab464fe2c69e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9918/5730903/1a27cea97b48/gr4.jpg

相似文献

1
Bulbocavernosus muscle area as a novel marker for hypogonadism.球海绵体肌面积作为性腺功能减退的一种新型标志物。
Asian J Urol. 2017 Jan;4(1):3-9. doi: 10.1016/j.ajur.2016.11.002. Epub 2016 Nov 28.
2
Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.睾酮的去势水平导致雄激素敏感的会阴肌肉萎缩:一种男性性腺功能减退的潜在生物标志物。
Urology. 2025 Feb;196:313-320. doi: 10.1016/j.urology.2024.10.006. Epub 2024 Oct 18.
3
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.在患有获得性免疫缺陷综合征且出现消瘦的性腺功能减退男性中,去脂体重和肌肉量的减少与雄激素水平相关。
J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8. doi: 10.1210/jcem.81.11.8923860.
4
Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.长期睾酮替代疗法对高促性腺激素性性腺功能减退男性骨矿物质含量的影响。
Andrologia. 2001 Jan;33(1):47-52. doi: 10.1046/j.1439-0272.2001.00417.x.
5
Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity.球海绵体肌面积测量:一种评估雄激素活性的新方法。
Asian J Androl. 2014 Jul-Aug;16(4):618-22. doi: 10.4103/1008-682X.123681.
6
Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.HIV/AIDS 男性性腺功能减退症的最佳诊断方法和阈值:两种经皮睾酮替代治疗凝胶的比较。
Postgrad Med. 2013 Mar;125(2):30-9. doi: 10.3810/pgm.2013.03.2639.
7
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.性腺功能减退及睾酮增强疗法对碱性磷酸酶和骨密度的影响。
BJU Int. 2015 Mar;115(3):480-5. doi: 10.1111/bju.12870. Epub 2015 Jan 21.
8
Osteoporosis in men with hypogonadism because of ApoA-I Leu75Pro amyloidosis under long-term testosterone therapy.因载脂蛋白 A-I 亮氨酸 75 脯氨酸淀粉样变性导致的性腺功能减退症男性患者在长期睾酮治疗中出现骨质疏松症。
Andrology. 2023 Sep;11(6):1077-1085. doi: 10.1111/andr.13376. Epub 2023 Jan 23.
9
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.男性衰老相关的性腺功能减退症的诊断、潜在获益和睾酮补充治疗的风险。
Int J Endocrinol. 2012;2012:625434. doi: 10.1155/2012/625434. Epub 2012 Mar 14.
10
Sperm Count and Hypogonadism as Markers of General Male Health.精子数量和性腺功能减退症作为男性整体健康的标志物。
Eur Urol Focus. 2021 Jan;7(1):205-213. doi: 10.1016/j.euf.2019.08.001. Epub 2019 Aug 17.

引用本文的文献

1
Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.睾酮的去势水平导致雄激素敏感的会阴肌肉萎缩:一种男性性腺功能减退的潜在生物标志物。
Urology. 2025 Feb;196:313-320. doi: 10.1016/j.urology.2024.10.006. Epub 2024 Oct 18.
2
Ejaculatory dysfunction in men with diabetes mellitus.糖尿病男性的射精功能障碍
World J Diabetes. 2021 Jul 15;12(7):954-974. doi: 10.4239/wjd.v12.i7.954.
3
News from leading international academic urology departments.来自国际领先泌尿外科系的消息。

本文引用的文献

1
Effects of Testosterone Treatment in Older Men.睾酮治疗对老年男性的影响。
N Engl J Med. 2016 Feb 18;374(7):611-24. doi: 10.1056/NEJMoa1506119.
2
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study.2%睾酮溶液对性腺功能减退男性睾酮浓度、性欲及精力的影响:一项安慰剂对照研究的结果
J Urol. 2016 Mar;195(3):699-705. doi: 10.1016/j.juro.2015.10.083. Epub 2015 Oct 20.
3
Testosterone and "Age-Related Hypogonadism"--FDA Concerns.睾酮与“年龄相关性性腺功能减退”——美国食品药品监督管理局的担忧
Asian J Urol. 2017 Jan;4(1):1-2. doi: 10.1016/j.ajur.2016.11.001. Epub 2016 Nov 19.
N Engl J Med. 2015 Aug 20;373(8):689-91. doi: 10.1056/NEJMp1506632.
4
Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.睾酮水平正常化与男性心肌梗死和死亡率的降低有关。
Eur Heart J. 2015 Oct 21;36(40):2706-15. doi: 10.1093/eurheartj/ehv346. Epub 2015 Aug 6.
5
The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism.“损骨类镇痛药”悬案:阿片类药物对骨代谢的内分泌影响
Ther Clin Risk Manag. 2015 Mar 31;11:515-23. doi: 10.2147/TCRM.S79409. eCollection 2015.
6
Testosterone therapy and cardiovascular risk: advances and controversies.睾酮治疗与心血管风险:进展与争议
Mayo Clin Proc. 2015 Feb;90(2):224-51. doi: 10.1016/j.mayocp.2014.10.011.
7
Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.主题:骨骼、生殖与泌尿系统药物咨询委员会(BRUDAC)和药物安全与风险管理咨询委员会(DSARM AC)联席会议,2014年9月17日
J Urol. 2015 Feb;193(2):623-5. doi: 10.1016/j.juro.2014.11.060. Epub 2014 Nov 15.
8
The impact of exogenic testosterone and nortestosterone-decanoate toxicological evaluation using a rat model.使用大鼠模型对外源性睾酮和癸酸诺龙进行毒理学评估的影响。
PLoS One. 2014 Oct 10;9(10):e109219. doi: 10.1371/journal.pone.0109219. eCollection 2014.
9
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.与促睾酮药物相关的心血管风险:一项系统评价与荟萃分析
Expert Opin Drug Saf. 2014 Oct;13(10):1327-51. doi: 10.1517/14740338.2014.950653. Epub 2014 Aug 19.
10
Testosterone and weight loss: the evidence.睾酮与体重减轻:证据
Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):313-22. doi: 10.1097/MED.0000000000000086.